Academic Journal
Q2Netherlands Heart Journal
About Netherlands Heart Journal
Netherlands Heart Journal is a scholarly journal published by Bohn Stafleu van Loghum. SCImago 2025 lists it in Q2, with an SJR of 0.79 and H-index of 53.
Coverage: 2005-2026. Research categories: Cardiology and Cardiovascular Medicine (Q2).
Verified field sources
- Journal Impact Factor: 2.5 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Cardiac Arrhythmias and Treatments; Cardiac Imaging and Diagnostics; Cardiac pacing and defibrillation studies; Cardiac electrophysiology and arrhythmias; Acute Myocardial Infarction Research; Atrial Fibrillation Management and Outcomes.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
0.00 USD
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
The value of repeating genetic analysis over time illustrated by familial childhood onset HCM caused by a homozygous LZTR1 variant
A. E. van den Hazel, Q. Waisfisz, P. G. Postema, A. C. Houweling et al.
2026-09-28 · DOI: 10.1007/s12471-026-02069-zWeight management in cardiology practice: challenges and opportunities
Maarten J. G. Leening, Fabrice M. A. C. Martens, Martin E. W. Hemels
2026-10 · DOI: 10.1007/s12471-026-02075-1Prognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure
Yoran Crum, Dirk J. van Veldhuisen, Michelle Lobeek, Adriaan A. Voors et al.
2026-10 · DOI: 10.1007/s12471-026-02077-zObesity and cardiovascular disease: Time for a paradigm shift
Martin E. W. Hemels
2026-10 · DOI: 10.1007/s12471-026-02080-4Obesity, incretin-based therapies, and cardiovascular disease in women
Miro Salih, Yannicke A. J. Sloots, Martin E. W. Hemels, Laura M. G. Meems et al.
2026-10 · DOI: 10.1007/s12471-026-02084-0DUTCH weight control in atrial fibrillation study (DUTCH-WAIST)
Leonard Voorhout, Ron Pisters, Menno Huisman, Erik Klok et al.
2026-10 · DOI: 10.1007/s12471-026-02074-2Beyond weight loss: the value of physical activity and exercise for improving cardiometabolic risk factors in individuals with overweight and obesity
Bente M. de Roos, Valerie M. Monpellier, Dominique Hansen, Thijs M. H. Eijsvogels et al.
2026-10 · DOI: 10.1007/s12471-026-02076-0Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review
Susan J. F. van Maren, Eveline P. M. van Doorn, Mark M. Smits, Cees J. J. Tack et al.
2026-10 · DOI: 10.1007/s12471-026-02073-3Effects on atrial fibrillation symptom burden of an obesity-focused cardiac rehabilitation program: Insights from the OPTICARE XL trial
Nicole Tenbült-van Limpt, Richard A. J. Post, Nienke ter Hoeve, Iris den Uijl et al.
2026-10 · DOI: 10.1007/s12471-026-02079-xWhen atrial “smoke” signals bioprosthetic mitral valve thrombosis
Marta Catarina Almeida, Francisco Sampaio, Gustavo Pires-Morais, Bruno Melica et al.
2026-08-25 · DOI: 10.1007/s12471-026-02070-6Invasive and echocardiographic gradients of self- and balloon-expandable valves in failing aortic bioprostheses
Sraman Chatterjee, Mark van den Dorpel, Rik Adrichem, Claire Ben Ren et al.
2026-09 · DOI: 10.1007/s12471-026-02061-7Correction to: Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial
Victor A. Verpalen, Casper F. Coerkamp, Mark J. Hinderks, Joan G. Meeder et al.
2026-09 · DOI: 10.1007/s12471-026-02071-5The Dutch cardiomyopathy registry (DCR); rationale and registry design
Peter-Paul Zwetsloot, Michiel T. H. M. Henkens, Erik P. A. van Iperen, Michiel Minten et al.
2026-09 · DOI: 10.1007/s12471-026-02063-5Study designs and outcomes
Pim van der Harst
2026-09 · DOI: 10.1007/s12471-026-02072-4Optical coherence tomography-guided orbital atherectomy for calcified coronary lesions: rationale and design of the CROWN study
Eleni Ntantou, Alexandros A. Siskos, Nicolas M. van Mieghem, Joost Daemen et al.
2026-09 · DOI: 10.1007/s12471-026-02055-5The feasibility of the introduction of the Ross program in adults: early safety and quality outcomes in a single center
Nabil Saouti, Anthonie L. Duijnhouwer, Tim J. Ten Cate, Arie P. J. van Dijk et al.
2026-09 · DOI: 10.1007/s12471-026-02062-6Beyond ST elevation: Recognizing STEMI-Equivalent patterns
Ana Rodrigo Costa, Joana Laranjeira Correia, Aurora Andrade
2026-07-24 · DOI: 10.1007/s12471-026-02066-2Beyond ST elevation: Recognizing STEMI-Equivalent patterns
Ana Rodrigo Costa, Joana Laranjeira Correia, Aurora Andrade
2026-07-24 · DOI: 10.1007/s12471-026-02067-1An old drug, a classic signature
Francisco Rodrigues dos Santos, Mariana Duarte Almeida, Davide Moreira, João Miguel Santos et al.
2026-09 · DOI: 10.1007/s12471-026-02065-3An old drug, a classic signature
Francisco Rodrigues dos Santos, Mariana Duarte Almeida, Davide Moreira, João Miguel Santos et al.
2026-09 · DOI: 10.1007/s12471-026-02064-4Reviews
Community Reviews
Version History
October 2, 2026 at 8:58 pm
October 2, 2026